Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura

NCT00415532 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Thrombocytopenic Purpura
Thrombocytopenia
Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Thrombocytopenic Purpura

Interventions

DRUG: Medical Standard of Care for ITP
BIOLOGICAL: Romiplostim

Sponsor

Amgen